An interventional study of Intratissue Percutaneous Electrolysis and Dry Needling in Shoulder Pain and Myofascial Pain Syndrome, sponsored by University of Salamanca. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2023-05-25.
Sponsored by University of Salamanca · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Shoulder Pain with a site in Spain — 10 open to participants now, 10 under way, none of them phase 3. Shoulder Pain · Spain.
Among the 52 studies in Shoulder Pain with a site in Spain, this one is the 30th largest by planned enrollment of the 49 interventional ones that give a count, is one of 3 that started in 2022, is one of 47 with no phase, and was the 27th registered.
738 studies on the registry are indexed under Shoulder Pain; 168 are open to participants now.
Browse Shoulder Pain studies →10 of the 52 studies in Shoulder Pain with a site in Spain are open now. Recruiting first, the newest first:
University of Alcala · Sites in Spain
Ages 18–80
University of Alcala · Sites in Spain
Ages 18–70 · Healthy volunteers
University of Seville · Sites in Spain
Ages 18+
Trak Health Solutions S.L. · Sites in Spain
Ages 18+
Universidad Complutense de Madrid · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 90 Shoulder Pain studies recruiting now, 25 (28%) set no upper age limit and 55 (61%) stop at 75 or younger; 3 take children under 18; 15 take healthy volunteers.
This study: 18 Years to 55 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2022.
This study's planned enrollment of 42 is below the median of 60 across 590 interventional studies indexed under Shoulder Pain.
Median enrollment 50 across the 49 interventional studies, 159 across the 3 observational. Of the 34 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 52 have an industry lead sponsor. The 10 most frequent:
University of Salamanca is the lead sponsor of 112 studies on the registry; 47 are open to participants now.
University of Salamanca has 1 study filed under Shoulder Pain — fewer than ten, so there is no comparison to draw.
4 of the studies in Shoulder Pain with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06296979University of SevilleEffectiveness of Noninvasive Phrenic Nerve Neuromodulation in Shoulder Pain and Hepatobiliary Visceral Comorbidity. | 2026-12-01 |
| NCT06398574University of AlcalaEffects of Dry Needling on the Behavior of the Shoulder Muscles | 2026-12-20 |
| NCT07637760Universidad Complutense de MadridDry Needling or Percutaneous Electrolysis for Managing Myofascial Trigger Points? | 2027-01-30 |
| NCT07621016Universidad Europea de ValenciaEffects of Dry Needling in Athletes With Subacromial Pain Syndrome | 2027-03 |
Add all 4 to your calendar (.ics) → With an account.
Among the 52 studies in Shoulder Pain with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This is a parallel-group randomised clinical trial:
Primary purpose: To analyse the clinical changes produced by two different physiotherapy treatments (Intratissue Percutaneous Electrolysis and Dry Needling) for myofascial trigger points in the infraspinatus muscle in subjects with non-specific shoulder pain.
Hypothesis: A physiotherapy treatment including Intratissue Percutaneous Electrolysis therapy present greater benefits in terms of pain reduction and increased mobility and functionality rather than Dry Needling treatment in subjects with non-specific shoulder pain.
The intervention consisted of 3 treatment sessions, different according to the group, once a week. Seven evaluation points were performed, two pre-intervention evaluations one week apart and after the second one the first treatment session was performed. The third and fourth assessments were prior to the second and third treatment sessions, one week apart. The fifth, sixth and seventh assessments were conducted one week, one month and two months after the last treatment session in each group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The treatment to be performed in the Intratissue percutaneus electrolysis Group will consist of: 1. Palpation and localization of the myofascial trigger points in the infraspinatus muscle of the affected shoulder. 2. Application of the ultrasound-guided intratissue percutaneus electroysis technique (1 or 2 approaches) on the myofascial trigger points with the greatest clinical manifestations for the subject. The needle will remain at intramuscular level without movement and a galvanic current discharge will be applied in the area, through the needle, whose intensity will oscillate between 0.5 and 3 milliAmperes (mA). 3. Performance of an eccentric work protocol of the infraspinatus muscle to reduce post-puncture pain.
Procedure: Intratissue Percutaneous Electrolysis
The treatment to be performed in the Dry Needling Group will consist of: 1. palpation and localization of myofascial trigger points in the infraspinatus muscle of the affected shoulder. 2. Application of the ultrasound-guided dry needling technique (1 or 2 approaches) on the myofascial trigger points with major clinical manifestations for the subject. The physiotherapist will move the needle into the muscle using Hong's rapid entry and exit technique. 3. Performance of an eccentric work protocol of the infraspinatus muscle to reduce post-puncture pain.
Procedure: Dry Needling
Each subject will undergo 3 treatment sessions spaced one week apart. Ultrasound-guided Intratissue Percutaneous Electrolysis in the myofascial trigger points of the infraspinatus muscle
Each subject will undergo 3 treatment sessions spaced one week apart. Ultrasound-guided dry needling in the myofascial trigger points of the infraspinatus muscle
Changes in Pain intensity, before, during and after the intervention
Numerical pain rating scale (score 0-10 points)
Time frame: 4 months (7 points)
Changes in Shoulder flexion range of motion, before, during and after the intervention
The range of motion in flexion will be measured with an inclinometer to assess changes in the mobility to shoulder pain subjects
Time frame: 4 months (7 points)
Changes in Shoulder external rotation range of motion, before, during and after the intervention
The range of motion in external rotation will be measured with an inclinometer to assess changes in the mobility to shoulder pain subjects
Time frame: 4 months (7 points)
Changes in Pressure pain threshold at proximal myofascial trigger point of the infraspinatus muscle, before, during and after the intervention
The pressure threshold will be recorded using a digital algometer.
Time frame: 4 months (7 points)
Changes in Pressure pain threshold at distal myofascial trigger point of the infraspinatus muscle, before, during and after the intervention
The pressure threshold will be recorded using a digital algometer (Pain Test™ FPIX 10)
Time frame: 4 months (7 points)
Changes in Strength in shoulder external rotation before, during and after the intervention
The strength will be recorded with wireless MicroFET 2: Hand-held dynamometer for force assessment.
Time frame: 4 months (7 points)
Changes in Hand grip strength, before, during and after the intervention
The strength will be recorded with Jamar Plus: Digital dynamometer to assess grip strength.
Time frame: 4 months (7 points)
Changes in Disability and functionality of the upper limb, before, during and after the intervention
To measure the upper limb disability and functionality we will use the Disabilities of the Arm, Shoulder and Hand (DASH), which is a validated questionnaire that measures the functionality and disability that shoulder pain generates in the subject.
Time frame: 4 months (7 points)
Started Feb 2022 (actual). Primary completion is estimated for Jul 2023, 17 months after the start.
Of 351 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 17 months is above that.
Counting every sponsor, half of 356 studies reached it within 11 months; a quarter within 4 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.